Dr. Keith Wells

With more than 35 years of experience, Keith has been involved in the development of more than 90 clinical stage and licensed vaccines and biopharmaceutical products. His invaluable knowledge strengthens Batavia Biosciences’ groundbreaking vaccine projects.

Dr. Wells has been involved in the battle against measles, mumps, rubella, varicella, rotavirus, vaccinia, encephalitis viruses, Zika virus, and seasonal and pandemic influenza. Recently, he advised the Biomedical Advanced Research and Development Authority (BARDA) on the advanced development, licensure, acquisition, and manufacturing scale-up of medical countermeasures.

Keith’s extensive experience across the biopharmaceutical industry and government organizations for the development of vaccines for emerging diseases will further power our vision to reduce human suffering from infectious diseases, cancer and rare diseases.

Dr. Wells: “I’m delighted to be a part of the Batavia Biosciences Scientific Advisory Board as they continue to develop and employ cutting edge technologies to produce vital vaccines and biopharmaceutical products to improve global health.”

Dr. Keith Wells - Scientific Advisory Board Batavia Biosciences

Low-cost viral vector manufacturing

High-throughput screening for viral vectors

Viral vector manufacturing

Maximizing protein expression